Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

HRAS G13R

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

FGF19 amplification + HRAS Q61R + TP53 672+2T>G (6)

FGF3 amplification + HRAS Q61R + TP53 672+2T>G (6)

FGF4 amplification + HRAS Q61R + TP53 672+2T>G (6)

HRAS Q61R + TP53 P278S + PD-L1 overexpression (1)

HRAS overexpression + PIK3CA amplification (1)

HRAS overexpression + PIK3CA mutation (1)

FGF19 amplification + HRAS Q61R + TP53 672+2T>G (6)

FGF3 amplification + HRAS Q61R + TP53 672+2T>G (6)

FGF4 amplification + HRAS Q61R + TP53 672+2T>G (6)

HRAS Q61R + TP53 P278S + PD-L1 overexpression (1)

HRAS overexpression + PIK3CA amplification (1)

HRAS overexpression + PIK3CA mutation (1)

›

Thyroid Gland Anaplastic Carcinoma

Sensitive: D – Preclinical

Sensitive: D – Preclinical